Summit for Clinical Ops Executives 2026

About the event Detail Information Event SCOPE Summit 2026, Summit for Clinical Ops Executives Dates February 2–5, 2026 Venue Rosen Shingle Creek Address 9939 Universal Boulevard, Orlando, FL 32819 City Orlando State / Region Florida Country United States Organizer Cambridge Healthtech Institute Event Type B2B Executive Conference, Exhibition, Clinical Research Summit, Partnering Event Primary Category from your list Medical & Pharma Secondary Categories IT & Technology, Science & Research, Business Services, Logistics & Transportation Audience Reach Global 2026 Actual Attendance 5,000+ attendees Companies Represented 1,200+ companies Countries Represented 30 countries Speakers 800+ Exhibitors 350+ Decision-making level About 60% in key decision-making roles The venue address is confirmed by SCOPE's official hotel page, while the final post-event profile reports 5,000+ attendees, 1,200+ companies, 30 countries and about 60% decision-makers. 1️⃣ Who attends, BUYERS / ATTENDEES For your attendee-data business, this is a very strong buyer-oriented event. The most valuable audience is not doctors attending for CME. It is corporate clinical-development and clinical-operations leadership controlling trial budgets, CRO relationships, technology platforms, sites, labs, recruitment and clinical supply. Buyer group Buyer quality Typical purchasing responsibility Pharmaceutical companies ⭐⭐⭐⭐⭐ CROs, eClinical technology, clinical sites, labs, recruitment, logistics, data services Biotechnology companies ⭐⭐⭐⭐⭐ Clinical outsourcing, trial management, regulatory support, sites, vendors Medical device companies ⭐⭐⭐⭐½ Clinical research, monitoring, trial technology, sites, data Emerging biopharma ⭐⭐⭐⭐⭐ Heavy outsourcing requirement, CROs, consultants, trial technology Healthcare systems / research hospitals ⭐⭐⭐⭐ Research technology, trial platforms, sponsors, site partnerships CROs ⭐⭐⭐⭐ Technology, data, recruitment, labs, subcontractors Investigative site networks ⭐⭐⭐⭐ Sponsor partnerships, patient recruitment, CTMS, eClinical technology Clinical technology companies More seller than buyer Mainly exhibitors / solution providers Investors / venture capital Specialized ClinTech, biotech, trial innovation investments SCOPE's own detailed demographic material showed a prior audience mix of 23% biotech, 19% pharma, 16% CRO, 16% services, 13% healthcare, 9% financial, 3% academic, 1% societies, while the final 2026 profile confirms continued participation from pharma, biotech, CROs, sites, technology, investment and patient-advocacy organizations. 2️⃣ Event geography + attendee origin Event location: Orlando, Florida, United States. Attendee origin: Global. The final organizer data says attendees represented 30 countries. The organizer does not publicly provide a reliable final country-by-country percentage breakdown, so I would not claim exact geographic percentages in a sales pitch. For an Apollo sample campaign before knowing your client's product, I recommend this prospecting mix, rather than presenting it as official attendee distribution: Country Suggested records in a 10-record sample United States 6 United Kingdom 1 Germany 1 Switzerland 1 Canada 1 If you want only 5 samples, start with United States 3, United Kingdom 1, Switzerland 1. Once I see your client's website, I may change this completely based on their product. 3️⃣ Audience reach Rating: GLOBAL 🌍, 9.5/10 The event is held in the United States and therefore naturally has a strong North American core, but its 30-country attendance, 1,200+ participating companies and multinational pharmaceutical speaker base make it a genuine international clinical-research event rather than a local Florida show. 4️⃣ Best sample BUYER companies These are buyer-side organizations, primarily pharma, biotech, medical-device and healthcare organizations. I have intentionally left normal clinical-tech vendors and most CRO service sellers out of this first buyer sample. Priority Buyer Company Website Why suitable ⭐⭐⭐⭐⭐ AbbVie www.abbvie.com Major global clinical development organization ⭐⭐⭐⭐⭐ Amgen www.amgen.com Global study operations, clinical systems, trial technology ⭐⭐⭐⭐⭐ AstraZeneca www.astrazeneca.com Clinical operations, feasibility, data, trial innovation ⭐⭐⭐⭐⭐ Bristol Myers Squibb www.bms.com Global development operations, monitoring, technology ⭐⭐⭐⭐⭐ Daiichi Sankyo www.daiichisankyo.com Clinical operations, recruitment, patient engagement ⭐⭐⭐⭐⭐ Eli Lilly and Company www.lilly.com Clinical research, digital trials, clinical technology ⭐⭐⭐⭐⭐ Gilead Sciences www.gilead.com Clinical data science, trial operations ⭐⭐⭐⭐⭐ GSK www.gsk.com Global clinical operations, clinical R&D ⭐⭐⭐⭐⭐ Johnson & Johnson www.jnj.com Clinical development, innovation, digital health ⭐⭐⭐⭐⭐ Merck & Co. www.merck.com Clinical development, operations, trial technology ⭐⭐⭐⭐⭐ Moderna www.modernatx.com Clinical operations, patient recruitment, clinical development ⭐⭐⭐⭐⭐ Novartis www.novartis.com Clinical operations, translational medicine, feasibility ⭐⭐⭐⭐⭐ Pfizer www.pfizer.com Clinical R&D, clinical data sciences, trial operations ⭐⭐⭐⭐⭐ Roche www.roche.com Clinical operations, clinical development ⭐⭐⭐⭐⭐ Sanofi www.sanofi.com Global clinical operations, diversity, feasibility ⭐⭐⭐⭐⭐ Takeda www.takeda.com Clinical operations, site engagement, trial optimization ⭐⭐⭐⭐⭐ Vertex Pharmaceuticals www.vrtx.com Clinical strategy, data, operational development ⭐⭐⭐⭐⭐ Biogen www.biogen.com Global clinical operations, trial optimization ⭐⭐⭐⭐⭐ Boehringer Ingelheim www.boehringer-ingelheim.com Site strategy, clinical operations, trial engagement ⭐⭐⭐⭐⭐ Regeneron www.regeneron.com Precision medicine, clinical development These are particularly defensible sample targets because SCOPE's own 2026 sponsorship prospectus explicitly displayed companies such as AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Lilly, Gilead, GSK, Johnson & Johnson, Merck, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, Vertex, Biogen and Boehringer Ingelheim alongside clinical-research leadership roles. 5️⃣ Best job profiles For Apollo, I would start with: Chief Development Officer, Chief Medical Officer, Chief Scientific Officer, SVP Clinical Operations, Vice President Clinical Operations, VP Global Development Operations, Head of Clinical Operations, Head of Global Clinical Operations, Head of Study Operations, Executive Director Clinical Operations, Senior Director Clinical Operations, Director Clinical Operations, Clinical Operations Program Lead, Clinical Program Lead, Clinical Trial Lead, Vice President Clinical Development, Senior Director Clinical Development, Director Clinical Development, Head of Clinical Data Management, Vice President Clinical Data Sciences, Director Clinical Data Strategy, Director Clinical Systems, Head of Clinical Technology, Digital Trial Lead, Head of Patient Engagement, Director Patient Engagement, Head of Site Engagement, Director Site Engagement, Director Strategic Feasibility, Head of Feasibility, Clinical Outsourcing Director, Strategic Sourcing Director, Alliance Management Director, Clinical Procurement Director, Clinical Trial Supply Director, Clinical Supply Chain Director, Pharmacovigilance Director, Drug Safety Director, Clinical Quality Director, RBQM Director The event agenda confirms roles at this level from AstraZeneca, AbbVie, Bristol Myers Squibb, Pfizer, Amgen, Daiichi Sankyo, Novartis, Takeda and other sponsor organizations. 6️⃣ Attendance / total footfall There is no need to estimate anymore because 2026 has finished. Pre-event expectation: approximately 4,500+ clinical research professionals. Final reported result: 5,000+ attendees, 800+ speakers, 350+ exhibitors, 1,200+ companies, 30 countries. So for database-sales positioning, I would describe the addressable event audience as roughly 5,000+ clinical research professionals, not 4,500. 7️⃣ Main focus areas + buyer engagement The purchasing signals here are unusually strong. SCOPE ran programs covering trial design, protocol development, feasibility, site selection, patient recruitment, patient engagement, site operations, clinical budgeting, outsourcing, small biopharma operations, clinical data, AI, eClinical technology, digital endpoints, real-world evidence, RBQM, safety, pharmacovigilance, biospecimens, clinical supply, market access and ClinTech investment. Buyer engagement is also strong because the event combines conference sessions with a large exhibit hall, sponsored networking lunches, coffee networking, receptions, one-to-one networking, workshops, partnering and product demonstrations. In other words, this is not merely a lecture hall. It is built as a clinical-vendor marketplace wrapped inside an executive conference. Apollo Industry filter For the strongest buyer-only audience, use: Pharmaceuticals, Biotechnology, Medical Devices, Hospital & Health Care, Research, Medical Practice Depending on what your client sells, I may additionally use: Information Technology & Services, Computer Software, Logistics & Supply Chain, Packaging & Containers, Staffing & Recruiting, Health, Wellness & Fitness Apollo Keywords clinical trials, clinical research, clinical operations, clinical development, global study operations, clinical trial management, clinical outsourcing, CRO management, vendor management, clinical trial technology, eClinical, CTMS, EDC, eCOA, decentralized clinical trials, patient recruitment, patient engagement, site engagement, site selection, clinical feasibility, protocol optimization, clinical data management, clinical data science, clinical supply, clinical supply chain, pharmacovigilance, drug safety, RBQM, risk based quality management, biospecimen management, real world evidence, digital biomarkers, clinical AI, clinical trial innovation Best database value For attendee-list sales, I rate SCOPE: Event quality: 9.5/10 Buyer concentration: 9.5/10 Decision-maker quality: 9.5/10 Global reach: 9/10 Apollo prospecting potential: 10/10 One important distinction: SCOPE explicitly states that it does not sell its official attendee list. Therefore, a prospect database should be positioned as an independently researched list of relevant clinical-operations prospects / likely event audience, not as an "official SCOPE attendee list" unless attendance itself has been independently verified. Now send me your client's website This is the important next step. Send me the client website/domain that is buying the data from you. I will review what the client actually sells, identify who would buy that product at SCOPE, and then give you the exact best buyer companies, buyer countries and count, Apollo industries, keywords, job titles, companies to avoid, and 5 or 10 strongest sample-company websites. That will be much more accurate than targeting the whole SCOPE audience.